Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Churchill domain containing protein 1 (CHURC1) is a zinc finger-containing transcriptional activator that mediates fibroblast growth factor (FGF) signaling during neural development and has a role in regulating cell movement. It does not bind DNA directly and is believed to function via protein-protein interactions within the cell nucleus, contributing to neural tissue patterning and possibly other developmental processes[1][6][8]. There is no current evidence supporting its use as a direct therapeutic target, nor are there known drugs, clinical biomarkers, or safety challenges related to direct targeting of CHURC1 in medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Churchill domain containing protein 1 (CHURC1).